Den mulige patofysiologiske mekanisme omfatter immun- kompleksdannelse og aflejring på grund af antistofudvikling mod omalizumab.
The suggested pathophysiologic mechanism includes immune-complex formation and deposition due to development of antibodies against omalizumab.